Pictet Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Pictet Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,905	Closed	-$421K	–	2119
2025 Q4	$421K	Buy	+1,905	New	+$308K	﹤0.01%	1532

Pictet Asset Management's CDTX Position: Q1 2026 in Review

Pictet Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,905 shares — an estimated $421K sold.

Pictet Asset Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $421K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Pictet Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Pictet Asset Management sold 1,905 Cidara Therapeutics shares in Q1 2026, an estimated $421K.
Pictet Asset Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Pictet Asset Management's Cidara Therapeutics position peaked at $421K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.